Rigrodsky & Long, P.A. announces that it has commenced an investigation into possible breaches of fiduciary duty and other violations of law by certain officers and directors of LHC Group, Inc. (Nasdaq: LHCG) (“LHC Group” or the “Company”).

On September 30, 2011, the United States Department of Justice announced that LHC Group agreed to pay $65 million, plus interest, to the federal government to resolve allegations that it violated the False Claims Act for false home healthcare billings to the Medicare, TRICARE and Federal Employees Health Benefits programs.  The Company also agreed to be bound by the terms of a Corporate Integrity Agreement with the Department of Health and Human Services – Office of Inspector General (HHS-OIG).

It is alleged that LHC Group violated the False Claims Act by (1) billing for services without a valid plan of care, (2) resequencing and upcoding ICD-9-CM diagnosis codes, (3) billing for services not rendered or not supported by the required documentation, (4) billing for services without physician orders, or for more services than ordered by the physician, (5) billing for services that were not medically necessary, and (6) billing for services rendered to patients who were not homebound.

Rigrodsky & Long, P.A.’s investigation focuses on whether officials at LHC Group breached their fiduciary duties to shareholders and harmed the Company. 

If you invested in LHC Group between January 1, 2006 and December 31, 2008, still own LHC Group stock, and are interested in discussing your rights as a LHC Group shareholder, or have information relating to this investigation, please contact Seth D. Rigrodsky, Esquire or Noah R. Wortman, Case Development Director, of Rigrodsky & Long, P.A., 919 N. Market Street, Suite 980, Wilmington, Delaware 19801, by telephone at (888) 969-4242, or by e-mail to info@rigrodskylong.com.

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly litigates securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, including claims for breach of fiduciary duty and proxy violations in the Delaware Court of Chancery and in state and federal courts throughout the United States.

Attorney advertising.  Prior results do not guarantee a similar outcome.